Cargando…

Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer

BACKGROUND: Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a candidate diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma (PDAC). Here, we determined the possible association of systemic TIMP-1 levels with cachexia and jaundice, two common PDAC-associated conditions. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prokopchuk, Olga, Grünwald, Barbara, Nitsche, Ulrich, Jäger, Carsten, Prokopchuk, Oleksii L., Schubert, Elaine C., Friess, Helmut, Martignoni, Marc E., Krüger, Achim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797345/ https://www.ncbi.nlm.nih.gov/pubmed/29394913 http://dx.doi.org/10.1186/s12885-018-4055-9

Ejemplares similares

A novel tissue inhibitor of metalloproteinases‐1/liver/cachexia score predicts prognosis of gastrointestinal cancer patients
por: Prokopchuk, Olga, et al.
Publicado: (2021)

Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia – can findings from animal models be translated to humans?
por: Mueller, Tara C., et al.
Publicado: (2016)

Diabetes increases mortality in patients with pancreatic and colorectal cancer by promoting cachexia and its associated inflammatory status
por: Chovsepian, Alexandra, et al.
Publicado: (2023)

The clinical picture of cachexia: a mosaic of different parameters (experience of 503 patients)
por: Schwarz, S., et al.
Publicado: (2017)

TIMP1 expression underlies sex disparity in liver metastasis and survival in pancreatic cancer
por: Hermann, Chris D., et al.
Publicado: (2021)

Measurement of body mass by bioelectrical impedance analysis and computed tomography in cancer patients with malnutrition – a cross-sectional observational study
por: Mueller, Tara Catharina, et al.
Publicado: (2020)

Cancer cachexia
por: Martignoni, Marcus E, et al.
Publicado: (2003)

Pancreatic cancerrelated cachexia: influence on metabolism and correlation to weight loss and pulmonary function
por: Bachmann, Jeannine, et al.
Publicado: (2009)

Specific miRNAs are associated with human cancer cachexia in an organ‐specific manner
por: Krauss, Tanja, et al.
Publicado: (2023)

Matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor 2 (TIMP-2) in pancreatic cancer (PC)
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2019)

Multiple intestinal intussusceptions caused by highly impaired gastrointestinal motility in a patient with chronic cannabis consumption
por: Prokopchuk, Olga, et al.
Publicado: (2019)

Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions
por: Prokopchuk, O, et al.
Publicado: (2005)

Association of Matrix Metalloproteinases -7, -8 and -9 and TIMP -1 with Disease Severity in Acute Pancreatitis. A Cohort Study
por: Nukarinen, Eija, et al.
Publicado: (2016)

Maffucci syndrome and neoplasms: a case report and review of the literature
por: Prokopchuk, Olga, et al.
Publicado: (2016)

A proposal for a new clinical classification of chronic pancreatitis
por: Büchler, Markus W, et al.
Publicado: (2009)

Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a therapy
por: Morigny, Pauline, et al.
Publicado: (2021)

TIMP-1 is a novel ligand of Amyloid Precursor Protein and triggers a proinflammatory phenotype in human monocytes
por: Eckfeld, Celina, et al.
Publicado: (2023)

Gene Expression of Matrix Metalloproteinases and their Inhibitors (TIMPs) in Meningiomas of Dogs
por: Mandara, M.T., et al.
Publicado: (2017)

MRI-Determined Psoas Muscle Fat Infiltration Correlates with Severity of Weight Loss during Cancer Cachexia
por: Patzelt, Lisa, et al.
Publicado: (2021)

Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP
por: Becher, Naja, et al.
Publicado: (2008)

ROC analysis of selected matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in psoriatic patients
por: Glazewska, Edyta K., et al.
Publicado: (2018)

Elevated levels of tissue inhibitor of metalloproteinases (TIMPS) in human hepatocellular carcinomas
por: Matsumoto, Eiji, et al.
Publicado: (2004)

Circulating Tissue Inhibitor of Matrix Metalloproteinase-4 (TIMP-4) in Systemic Sclerosis Patients with Elevated Pulmonary Arterial Pressure
por: Gialafos, Elias J., et al.
Publicado: (2008)

Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs)
por: Okazaki, Isao, et al.
Publicado: (2014)

Arterial Resection for Pancreatic Cancer: Feasibility and Current Standing in a High-Volume Center
por: Ren, Lei, et al.
Publicado: (2023)

Bacterial content of the human pancreatic duct: An observational study
por: Demir, Elke, et al.
Publicado: (2022)

Matrix metalloproteinases and their inhibitors in pediatric severe acute pancreatitis
por: Vitale, David S., et al.
Publicado: (2022)

Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS)
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2014)

Imbalances between Matrix Metalloproteinases (MMPs) and Tissue Inhibitor of Metalloproteinases (TIMPs) in Maternal Serum during Preterm Labor
por: Tency, Inge, et al.
Publicado: (2012)

Matrix metalloproteinases (MMPs) and inhibitor of metalloproteinases (TIMP) mRNA and protein expression in laryngeal squamous cell carcinoma
por: Grzelczyk, Weronika Lucas, et al.
Publicado: (2019)

Should every patient with pancreatic cancer receive perioperative/neoadjuvant therapy?
por: Nitsche, Ulrich, et al.
Publicado: (2016)

On the Enhanced Accuracy of Kinetic Curve Building in Supercritical Fluid Extraction from Aroma Plants Using a New 3D-Printed Extract Collection Device
por: Prokopchuk, Denis, et al.
Publicado: (2020)

An evaluation of matrix metalloproteinase-9 (Mmp-9) and tissue inhibitor metalloproteinase-1 (Timp-1) Serum levels and the Mmp-9/Timp-1 Ratio in Covid-19 patients
por: Demir, Nazlim Aktug, et al.
Publicado: (2023)

Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease.
por: Bramhall, S. R., et al.
Publicado: (1996)

Matrix Metalloproteinase-10/TIMP-2 Structure and Analyses Define Conserved Core Interactions and Diverse Exosite Interactions in MMP/TIMP Complexes
por: Batra, Jyotica, et al.
Publicado: (2013)

Expressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases
por: Jakubowska, Katarzyna, et al.
Publicado: (2016)

Matrix metalloproteinase MMP-8, TIMP-1 and MMP-8/TIMP-1 ratio in plasma in methicillin-sensitive Staphylococcus aureus bacteremia
por: Forsblom, Erik, et al.
Publicado: (2021)

Tranexamic Acid to Treat Life-threatening Hemorrhage in Prostate Cancer Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis
por: Prokopchuk-Gauk, Oksana, et al.
Publicado: (2015)

The Activity of Matrix Metalloproteinases (MMP-2, MMP-9) and Their Tissue Inhibitors (TIMP-1, TIMP-3) in the Cerebral Cortex and Hippocampus in Experimental Acanthamoebiasis
por: Łanocha-Arendarczyk, Natalia, et al.
Publicado: (2018)

Angiotensin II Differentially Induces Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Production and Disturbs MMP/TIMP Balance
por: Yaghooti, Hamid, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ev0kcg4e13s8o67p2h4lk9a5fe